Lamattina John L
CIK 0001216074
Director
Filings
10
Latest Mar 31, 2026
Issuers covered
2
Showing
10 of 10
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +6.9% | +8.8% | +10.9% | -0.8% |
| 90 days | 4 | 75% | -0.8% | +4.2% | +5.3% | -16.8% |
| 180 days | 3 | 33% | -4.2% | -14.9% | +17.1% | -14.9% |
| 365 days | 1 | 0% | -65.8% | -65.8% | -65.8% | -65.8% |
Issuers
Companies where Lamattina John L has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 7 | Mar 31, 2026 |
| IMNM | Immunome Inc. | 3 | Jun 12, 2023 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|